March 2026
1. DENG KQ, Xu Z, Wang Q, Cai HH, et al
   Inhibition of Annexin A2 Facilitates PHB2-Mediated Mitophagy in Cardiomyocytes to Alleviate Cardiac Injury and Remodeling After Infarction.
   Circulation. 2026;153:826-844.
   

   >> Share

   
   
2. DHRUVA SS
   Role of High-Dose Influenza Vaccine in Reducing Cardiovascular Risk.
   Circulation. 2026;153:807-809.
   

   >> Share

   
   
3. WATSON KE, Fonarow GC
   The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment.
   Circulation. 2026 Mar 13. doi: 10.1161/CIRCULATIONAHA.126.079538.
   

   >> Share

   
   
4. ZHU X, Li W, Yu J
   Letter by Zhu et al Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
   Circulation. 2026;153:e913.
   

   >> Share

   
   
5. CHU L, Ma X, Chen K
   Response by Chu et al to Letter Regarding Article, "Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States".
   Circulation. 2026;153:e914-e915.
   

   >> Share

   
   
6. ARAIZA-GARAYGORDOBIL D, Garcia-Jimenez Y, Gopar-Nieto R
   Global Rounds Mexico: Improving Cardiovascular Health Through Integration.
   Circulation. 2026;153:696-698.
   

   >> Share

   
   
7. HE J, Zhu Y
   Correction to: Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
   Circulation. 2026;153:e909.
   

   >> Share

   
   
8. JARR KU, Peters A, Leeper NJ
   Microplastics and Nanoplastics: A New Perspective in Cardiovascular Prevention.
   Circulation. 2026;153:613-615.
   

   >> Share

   
   February 2026
9. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
   Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
   Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
   

   >> Share

   
   
10. XIE J, Cheng LM, Liu K
    Letter by Xie et al Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e109-e110.
    

    >> Share

    
    
11. HUANG J, Fogacci F
    Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e111-e112.
    

    >> Share

    
    
12. BERRY JD, Leonard D, Levine BD, DeFina LF, et al
    Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
    Circulation. 2026;153:e113-e114.
    

    >> Share

    
    
13. CARNETHON MR, Post WS, Hill JA, Al-Khatib SM, et al
    Go(ing) Red for Women and Fulfilling Our Commitment to Sex-Based Reporting of Cardiovascular Disease.
    Circulation. 2026;153:467-468.
    

    >> Share

    
    
14. GRAGNANO F, Giacoppo D, Choi KH, Kimura T, et al
    Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials.
    Circulation. 2026;153:543-546.
    

    >> Share

    
    
15. ROSEN SE
    Redefining Cardiovascular Medicine: The Journey From "Does Sex Matter?" to "How Does Sex Matter?".
    Circulation. 2026;153:534-535.
    

    >> Share

    
    
16. BOYER TM, Barrett RB, Xiong C, Bu F, et al
    Hypertensive Disorders of Pregnancy and Premature Cardiovascular Disease in a Diverse Cohort of Young US Women.
    Circulation. 2026;153:480-492.
    

    >> Share

    
    
17. LI N, Hao Z, Yang H, Cai J, et al
    CCR8 Expression on Regulatory T Cells Reveals Trajectories of Tissue Adaptation and Protects Against Myocardial Infarction-Induced Tissue Damage.
    Circulation. 2026 Feb 13. doi: 10.1161/CIRCULATIONAHA.125.076426.
    

    >> Share

    
    
18. DARDARI ZA, Yao Z, Zhang J, Bakoyannis G, et al
    Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration.
    Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.075327.
    

    >> Share

    
    
19. BAI X, Ren R, Yuan J, Yu L, et al
    Macrophage PRMT9 Ameliorates Acute Myocardial Infarction by Promoting Symmetric Dimethylation and Degradation of STAT1.
    Circulation. 2026 Feb 11. doi: 10.1161/CIRCULATIONAHA.125.076101.
    

    >> Share

    
    
20. KHAN SS, Greenland P, Hayman LL, Khera R, et al
    Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 11. doi: 10.1161/CIR.0000000000001401.
    

    >> Share

    
    
21. MADHAVAN MV, Gregson J, Redfors B, Chen S, et al
    Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial.
    Circulation. 2026 Feb 10. doi: 10.1161/CIRCULATIONAHA.125.075875.
    

    >> Share

    
    
22. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    

    >> Share

    
    
23. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    

    >> Share

    
    
24. WU Y, Nguyen T, Wang Y, Zhou Y, et al
    Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.
    Circulation. 2026;153:463-466.
    

    >> Share

    
    
25. RHEE JW, Bolton KL, Gupta D, Weeks LD, et al
    Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 10. doi: 10.1161/CIR.0000000000001404.
    

    >> Share

    
    
26. VON HUNDELSHAUSEN P, Siess W, Duan R, Bohnert T, et al
    Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting.
    Circulation. 2026;153:435-456.
    

    >> Share

    
    
27. ZHANG L, Iliescu C, Ferencik M, Finamore V, et al
    Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 9. doi: 10.1161/CIR.0000000000001391.
    

    >> Share

    
    
28. LI X, Li X, Li CX, Feng J, et al
    TRPM7 Deficiency Protects Against Myocardial Ischemia-Reperfusion Injury by Regulating Intracellular Zn(2+) Homeostasis.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.074791.
    

    >> Share

    
    
29. BANGALORE S, Fearon WF, Fugar S, Dangas GD, et al
    Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e25-e41.
    

    >> Share

    
    
30. KOVACIC JC, Reynolds HR, Alasnag M, Blakeman JR, et al
    Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 3. doi: 10.1161/CIR.0000000000001416.
    

    >> Share

    
    January 2026
31. PAUWELS R, Dausin C, Ruiz-Carmona S, De Bosscher R, et al
    Wearable-Derived Training Load and Coronary Atherosclerosis in Middle-Aged and Older Athletes and Physically Active Controls: A New Perspective From the Master@Heart Study.
    Circulation. 2026 Jan 29. doi: 10.1161/CIRCULATIONAHA.125.077117.
    

    >> Share

    
    
32. CHANG Q, Li C, Xu Z
    An Atypical Presentation of an Occlusion Myocardial Infarction Requiring Urgent Revascularization.
    Circulation. 2026;153:282-284.
    

    >> Share

    
    
33. ARMSTRONG A, Pugh D, Basu N, Dhaun N, et al
    Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
    Circulation. 2026;153:266-281.
    

    >> Share

    
    
34. CHO Y, Kang D, Lim H, Lee H, et al
    Association of Statin Discontinuation in Pregnancy With Maternal Cardiovascular Health and Birth Outcomes: A Nationwide Cohort Study.
    Circulation. 2026 Jan 23. doi: 10.1161/CIRCULATIONAHA.125.078919.
    

    >> Share

    
    
35. HE J, Zhu Y
    Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction.
    Circulation. 2026;153:185-188.
    

    >> Share

    
    
36. PYRPYRIS N, Dimitriadis K, Tsioufis K
    Letter by Pyrpyris et al Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e14-e15.
    

    >> Share

    
    
37. MAENG M, Thrane PG, Erlinge D, Maehara A, et al
    Response by Maeng et al to Letters Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e17-e18.
    

    >> Share

    
    
38. SUN P
    Letter by Sun Regarding Article, "Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy".
    Circulation. 2026;153:e16.
    

    >> Share

    
    
39. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
    Correction to: Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
    Circulation. 2026;153:e19.
    

    >> Share

    
    
40. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A Statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    Circulation. 2026 Jan 20. doi: 10.1161/CIRCULATIONAHA.125.079034.
    

    >> Share

    
    
41. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Correction to: Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2026;153:e11.
    

    >> Share

    
    
42. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Response by Sittichokkananon et al to Letter Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e6-e7.
    

    >> Share

    
    
43. YANG S, Lu Y
    Letter by Yang and Lu Regarding Article, "Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes".
    Circulation. 2026;153:e4-e5.
    

    >> Share

    
    
44. ZHAO YT
    Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
    Circulation. 2026;153:e8-e9.
    

    >> Share

    
    
45. FEARON WF, Terada K, Takahashi K, Skoda A, et al
    Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
    Circulation. 2026;153:7-17.
    

    >> Share

    
    
46. LEONARDI S, Landi A, Zito A, Branca M, et al
    Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome.
    Circulation. 2026 Jan 6. doi: 10.1161/CIRCULATIONAHA.125.077174.
    

    >> Share

    
    December 2025
47. GUNAWARDENE MA, Schmidt B, Peichl P, Nair D, et al
    Life-Threatening Delayed Myocardial Ischemia and Malignant Arrhythmias Occurring After Pulsed Field Ablation of Atrial Fibrillation.
    Circulation. 2025 Dec 25. doi: 10.1161/CIRCULATIONAHA.125.077983.
    

    >> Share

    
    
48. HENRIKSEN PA
    Challenges of Clinical Trials in Cardio-Oncology: Navigating Surrogate Outcomes and Identifying Patients at Risk of Late Cardiovascular Complications.
    Circulation. 2025;152:1756-1758.
    

    >> Share

    
    
49. TRAN AH, Zaidi AH, Bolger AF, Del Brutto OH, et al
    Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 16. doi: 10.1161/CIR.0000000000001390.
    

    >> Share

    
    
50. XU L, Hrybouski S, Liao TE, Dong JN, et al
    Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
    Circulation. 2025;152:1608-1620.
    

    >> Share

    
    
51. SHARIF A
    Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk-Reducing Intervention in Kidney Failure.
    Circulation. 2025;152:1591-1593.
    

    >> Share

    
    
52. TOMCZYK M, Kraszewska I, Li G, Hayes MJ, et al
    Chordin-Like 1 mRNA Therapy for Acute Myocardial Infarction.
    Circulation. 2025;152:1586-1589.
    

    >> Share

    
    
53. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Chotai S, et al
    The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
    Circulation. 2025;152:1541-1551.
    

    >> Share

    
    
54. FETTERMAN JL, Chinnery PF, McClellan R, Wallace DC, et al
    Mitochondrial Genetics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Dec 2. doi: 10.1161/CIR.0000000000001393.
    

    >> Share

    
    
55. TSIMIKAS S, Szarek M, Cobbaert CM, Romijn F, et al
    Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes after Acute Coronary Syndrome.
    Circulation. 2025 Dec 1. doi: 10.1161/CIRCULATIONAHA.125.073855.
    

    >> Share

    
    November 2025
56. CHEN Y
    Letter by Chen Regarding Article, "Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality".
    Circulation. 2025;152:e407.
    

    >> Share

    
    
57. TULETA I, Venugopal H, O'Leary K, Zheng D, et al
    Fibroblast-Specific Loss of TGF-beta Signaling Mediates Lipomatous Metaplasia in the Infarcted Heart.
    Circulation. 2025;152:1423-1435.
    

    >> Share

    
    
58. DAMLUJI AA, Nanna MG, Mason P, Lowenstern A, et al
    Coronary Artery Revascularization in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 18. doi: 10.1161/CIR.0000000000001387.
    

    >> Share

    
    
59. LANDSTROM AP, Ferguson JF, James CA, Key KV, et al
    Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association.
    Circulation. 2025 Nov 13. doi: 10.1161/CIR.0000000000001385.
    

    >> Share

    
    
60. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2025;152:e402.
    

    >> Share

    
    
61. OHAYON-STECKEL L, Zhang X, Haque S, Uddin MA, et al
    miR-499 in Platelet-Derived Extracellular Vesicles Augments Inflammatory Cell Generation and Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.124.073527.
    

    >> Share

    
    
62. DUDUM R, Jain SS, Mastrodicasa D, Furst A, et al
    Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: the NOTIFY-PICTURE Trial.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.078155.
    

    >> Share

    
    
63. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
    High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis.
    Circulation. 2025 Nov 10. doi: 10.1161/CIRCULATIONAHA.125.077801.
    

    >> Share

    
    
64. SLIPCZUK L, Blankstein R, Bucciarelli-Ducci C, Braun LT, et al
    State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Nov 10. doi: 10.1161/CIR.0000000000001394.
    

    >> Share

    
    
65. LEMESLE G, Didier R, Diallo A, Dromas H, et al
    Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-term Anticoagulation: a Meta-analysis of Randomized Clinical Trials.
    Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.077141.
    

    >> Share

    
    
66. RAPOSEIRAS ROUBIN S, Abu Assi E, Jimenez Mendez C, Minguez de la Guia E, et al
    Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical Trial.
    Circulation. 2025 Nov 7. doi: 10.1161/CIRCULATIONAHA.125.075388.
    

    >> Share

    
    
67. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
    Correction to: Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
    Circulation. 2025;152:e371.
    

    >> Share

    
    October 2025
68. RUEL M
    Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.
    Circulation. 2025;152:1187.
    

    >> Share

    
    
69. DONOGHUE AJ, Auerbach M, Banerjee A, Blewer AL, et al
    Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
70. HIRSCH KG, Amorim E, Coppler PJ, Drennan IR, et al
    Part 11: Post-Cardiac Arrest Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
71. DEL RIOS M, Bartos JA, Panchal AR, Atkins DL, et al
    Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
72. PANCHAL AR, Bartos JA, Wyckoff MH, Drennan IR, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
73. JOYNER BL JR, Dewan M, Bavare A, de Caen A, et al
    Part 6: Pediatric Basic Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
74. ELMER J, Atkins DL, Daya MR, Del Rios M, et al
    Part 3: Ethics: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
75. CAO D, Arens AM, Chow SL, Easter SR, et al
    Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
76. KLEINMAN ME, Buick JE, Huber N, Idris AH, et al
    Part 7: Adult Basic Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
77. LEE HC, Strand ML, Finan E, Illuzzi J, et al
    Part 5: Neonatal Resuscitation: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
78. DEZFULIAN C, Cabanas JG, Buckley JR, Cash RE, et al
    Part 4: Systems of Care: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
79. LASA JJ, Dhillon GS, Duff JP, Hayes J, et al
    Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
80. WIGGINTON JG, Agarwal S, Bartos JA, Coute RA, et al
    Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2025;152.
    

    >> Share

    
    
81. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Andersen JT, et al
    Response by Windfeld-Mathiasen et al to Letter Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e296-e297.
    

    >> Share

    
    
82. KING SJ, Furst A, Fan J, Chen TP, et al
    Comparison of the Pooled Cohort and the PREVENT Cardiovascular Disease Risk Equations in the Veterans Health Administration.
    Circulation. 2025;152:1183-1185.
    

    >> Share

    
    
83. KORNELIUS E
    Letter by Kornelius Regarding Article, "Cardiovascular Disease in Anabolic Androgenic Steroid Users".
    Circulation. 2025;152:e295.
    

    >> Share

    
    
84. KOLE A, Joshi PH
    Clear as Mud: Determining the Stage of Prevention in Cardiovascular Disease.
    Circulation. 2025;152:1123-1125.
    

    >> Share

    
    
85. REGAN JA, Laitner MH, Dzau VJ
    A Crossroads in Cardiovascular Medicine: Progress and Barriers to Impact.
    Circulation. 2025;152:1166-1173.
    

    >> Share

    
    
86. CHEN X, Yu X, Zhong S, Sha P, et al
    ALDH2/eIF3E Interaction Modulates Protein Translation Critical for Cardiomyocyte Ferroptosis in Acute Myocardial Ischemia Injury.
    Circulation. 2025 Oct 20. doi: 10.1161/CIRCULATIONAHA.125.075220.
    

    >> Share

    
    
87. FORAKER R, Sperling L, Bratzke L, Budoff M, et al
    Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography: An Emerging Tool for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2025 Oct 16. doi: 10.1161/CIR.0000000000001382.
    

    >> Share

    
    
88. KHAN SS, Fisher SA
    Bending the Curve in Maternal Mortality: Pregnancy as a Moment for Cardiovascular Disease Prevention.
    Circulation. 2025;152:1056-1059.
    

    >> Share

    
    
89. LAU ES, D'Souza V, Zhao Y, Reeder C, et al
    Contemporary Burden of Cardiovascular Disease in Pregnancy: Insights From a Real-World Pregnancy Electronic Health Record Cohort.
    Circulation. 2025;152:1044-1055.
    

    >> Share

    
    
90. OREN O, Libby P
    Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice.
    Circulation. 2025;152:975-977.
    

    >> Share

    
    September 2025
91. VONGPATANASIN W, Abraham J, Giacona JM
    Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?
    Circulation. 2025;152:924-926.
    

    >> Share

    
    
92. SECHI LA, Bulfone L, Catena C
    Letter by Sechi et al Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e265-e266.
    

    >> Share

    
    
93. BHATIA HS, Tsimikas S
    Response by Bhatia and Tsimikas to Letter Regarding Article, "Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis".
    Circulation. 2025;152:e267-e268.
    

    >> Share

    
    
94. PETEK BJ, Churchill TW, Moulson N, Baggish AL, et al
    Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes.
    Circulation. 2025;152:971-973.
    

    >> Share

    
    
95. GENTILE F, Carapellucci E, Uggenti V, Lorenzoni V, et al
    Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074198.
    

    >> Share

    
    
96. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
    Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
    

    >> Share

    
    
97. GAN J, Zhao R, Zheng D, Peng Y, et al
    PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux.
    Circulation. 2025 Sep 24. doi: 10.1161/CIRCULATIONAHA.124.072312.
    

    >> Share

    
    
98. FENG S, Wang Z, Sun R
    Letter by Feng et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e239-e240.
    

    >> Share

    
    
99. ZHONG Y, Lai R, Deng X
    Letter by Zhong et al Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
    Circulation. 2025;152:e241-e242.
    

    >> Share

    
    
100. JI Y, Chen LY, Zhang MJ
     Response by Ji et al to Letters Regarding Article, "Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS".
     Circulation. 2025;152:e243-e244.
     

     >> Share

     
     
101. LEVINE GN, Carney RM, Cohen BE, Dunn SL, et al
     Post-Myocardial Infarction Psychological Distress: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Sep 22. doi: 10.1161/CIR.0000000000001381.
     

     >> Share

     
     
102. COUTINHO T
     The Geometry of Aging: New Angles on Cardiovascular Risk.
     Circulation. 2025;152:762-764.
     

     >> Share

     
     
103. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
     Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
     Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
     

     >> Share

     
     
104. SHI F, Zheng B, Liu Y
     Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e71-e72.
     

     >> Share

     
     
105. NAMBI V, de Lemos JA, Ballantyne CM
     A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
     Circulation. 2025;152:567-569.
     

     >> Share

     
     
106. KUEHN BM
     Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
     Circulation. 2025;152:630-631.
     

     >> Share

     
     
107. SILBERNAGEL G, Wen Y, Konrad RJ
     Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e73-e74.
     

     >> Share

     
     
108. HUANG J
     Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
     Circulation. 2025;152:e69-e70.
     

     >> Share

     
     
109. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
     Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
     Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
     

     >> Share

     
     August 2025
110. KHAN SS, Abdalla M, Bello NA, Blyler CA, et al
     Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Aug 28. doi: 10.1161/CIR.0000000000001355.
     

     >> Share

     
     
111. CHEN BY, Zhu H, Li YL, Zhang J, et al
     Oral Pathobionts Aggravate Myocardial Infarction Through Mobilization of B2 Cells.
     Circulation. 2025 Aug 27. doi: 10.1161/CIRCULATIONAHA.125.074837.
     

     >> Share

     
     
112. WU J, Zheng Y
     Letter by Wu and Zheng Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e67.
     

     >> Share

     
     
113. HO FK, Sattar N, Welsh P
     Response by Ho et al to Letter Regarding Article, "A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia".
     Circulation. 2025;152:e68.
     

     >> Share

     
     
114. QIN D, Modanwal R, Ghazi M, Corbalan JJ, et al
     Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.
     Circulation. 2025;152:486-488.
     

     >> Share

     
     
115. BERRY C, Carberry J, Dharmakumar R
     Intramyocardial Hemorrhage After Myocardial Infarction: A Prognostic Outcome for Clinical Practice and Trials.
     Circulation. 2025;152:349-351.
     

     >> Share

     
     
116. VIDOT DC
     Up in Smoke: No Association Between Cannabis Smoking and Cardiovascular Events Among Older Military Veterans With Coronary Artery Disease.
     Circulation. 2025;152:366-368.
     

     >> Share

     
     
117. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
     Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
     Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
     

     >> Share

     
     
118. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
     Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
     Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
     

     >> Share

     
     
119. BECKMAN JA, Drooz AT, Farber A, Hamdan A, et al
     The Impact of Coronary Artery Disease in Patients With Peripheral Artery Disease Undergoing Lower-Extremity Revascularization for Chronic Limb-Threatening Ischemia.
     Circulation. 2025;152:346-348.
     

     >> Share

     
     
120. TABAK RG, Kandula NR, Angell SY, Brewer LC, et al
     Implementation of Evidence-Based Behavioral Interventions for Cardiovascular Disease Prevention in Community Settings: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Aug 4. doi: 10.1161/CIR.0000000000001349.
     

     >> Share

     
     July 2025
121. WERESKI R, Morrow DA, Mills NL
     Unstable Angina Refined.
     Circulation. 2025;152:213-216.
     

     >> Share

     
     
122. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
     CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
     Circulation. 2025;152:257-273.
     

     >> Share

     
     
123. WANG J, Yang Bennett DS, Echard EJ, Chen B, et al
     Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction.
     Circulation. 2025 Jul 25. doi: 10.1161/CIRCULATIONAHA.125.073937.
     

     >> Share

     
     
124. KEYHANI S, Cohen BE, Vali M, Hoggatt KJ, et al
     Association of Smoking Cannabis With Cardiovascular Events Among Veterans With Coronary Artery Disease.
     Circulation. 2025 Jul 21. doi: 10.1161/CIRCULATIONAHA.124.073193.
     

     >> Share

     
     
125. CARBONNEAU M, Li Y, Qu Y, Zheng Y, et al
     DNA Methylation Signatures of Cardiovascular Health Provide Insights Into Diseases.
     Circulation. 2025 Jul 14:10.1161/CIRCULATIONAHA.124.073181.
     

     >> Share

     
     
126. BANN GG, Dos Santos M, Chen K, Tan W, et al
     Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction.
     Circulation. 2025 Jul 9. doi: 10.1161/CIRCULATIONAHA.124.072733.
     

     >> Share

     
     
127. GOUPIL R, Desbiens LC, Merabtine A, Agharazii M, et al
     Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study.
     Circulation. 2025 Jul 9:10.1161/CIRCULATIONAHA.124.073507.
     

     >> Share

     
     
128. HU Q, Zhang J, Luo X, Hu P, et al
     Intracellular L-PGDS-Derived 15d-PGJ2 Inhibits CaMKII Through Lipoxidation to Alleviate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2025;152:41-57.
     

     >> Share

     
     
129. HENDREN NS, Ammirati E
     Cardiovascular Effects of COVID-19: Legacy and Future Insights.
     Circulation. 2025;152:24-26.
     

     >> Share

     
     
130. CUEVAS C, Kikushima-Alcantara P, Miranda JJ
     The State of Cardiovascular Care in Peru: Needs for System Strengthening.
     Circulation. 2025;152:7-10.
     

     >> Share

     
     June 2025
131. GONG Y, Lu X, Wang X, Wang Y, et al
     Mitochondrial Tumor Suppressor 1A Attenuates Myocardial Infarction Injury by Maintaining the Coupling Between Mitochondria and Endoplasmic Reticulum.
     Circulation. 2025 Jun 30. doi: 10.1161/CIRCULATIONAHA.124.069737.
     

     >> Share

     
     
132. DUAN Z, Lin Z
     Response by Duan and Lin to Letter Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1093-e1094.
     

     >> Share

     
     
133. THRANE PG, Maeng M, Maehara A, Botker HE, et al
     Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
     Circulation. 2025;151:1767-1779.
     

     >> Share

     
     
134. WANG H, Zhao T, Zheng G
     Letter by Wang et al Regarding Article, "Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics".
     Circulation. 2025;151:e1091-e1092.
     

     >> Share

     
     
135. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e1098.
     

     >> Share

     
     
136. BELLAVIA A, Murphy SA
     Confounders, Effect Modifiers, and Mediators: Dealing With "Third Variables" in Cardiovascular Epidemiology.
     Circulation. 2025;151:1755-1757.
     

     >> Share

     
     
137. JOHNY E, Dutta P
     Targeting Extramedullary Hematopoiesis and Cardiac Immune Homing to Encourage Cardiac Healing After Myocardial Infarction.
     Circulation. 2025;151:1748-1751.
     

     >> Share

     
     
138. ARNAOUT R
     From Bytes to Beats: Overcoming Conceptual and Implementation Challenges for AI in Cardiovascular Care.
     Circulation. 2025;151:1697-1698.
     

     >> Share

     
     
139. GRECO M, Lombardi G, Brusasco C, Pieri M, et al
     Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial.
     Circulation. 2025 Jun 13. doi: 10.1161/CIRCULATIONAHA.125.075254.
     

     >> Share

     
     
140. CAMPO G, Pavasini R
     Response by Campo and Pavasini to Letter Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1049-e1050.
     

     >> Share

     
     
141. PAN D, Wu W, Chen M
     Letter by Pan et al Regarding Article, "Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis".
     Circulation. 2025;151:e1047-e1048.
     

     >> Share

     
     
142. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
     Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jun 9. doi: 10.1161/CIR.0000000000001341.
     

     >> Share

     
     
143. LEE S, Hwang SH, Park S, Son Y, et al
     Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.073086.
     

     >> Share

     
     
144. OBEL LM, Skovbo JS, Diederichsen ACP, Thomassen M, et al
     Aortic Aneurysm Risk and Somatic JAK2(V617F)Variation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study.
     Circulation. 2025 Jun 4. doi: 10.1161/CIRCULATIONAHA.125.074002.
     

     >> Share

     
     
145. CHU L, Wang R, Gross CP, Wei J, et al
     Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States.
     Circulation. 2025 Jun 3. doi: 10.1161/CIRCULATIONAHA.124.073614.
     

     >> Share

     
     
146. GREGSON J, Taylor D, Owen R, Collier T, et al
     Hierarchical Composite Outcomes and Win Ratio Methods in Cardiovascular Trials: A Review and Consequent Guidance.
     Circulation. 2025;151:1606-1619.
     

     >> Share

     
     May 2025
147. SCHNEEWEISS S, Kruger N
     Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine.
     Circulation. 2025;151:1495-1497.
     

     >> Share

     
     
148. BERRY C, McCartney P
     Letter by Berry and McCartney Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (The PITRI Trial)".
     Circulation. 2025;151:e1002-e1003.
     

     >> Share

     
     
149. BULLUCK H, Hausenloy DJ
     Response by Bulluck and Hausenloy to Letter Regarding Article, "Effect of Cangrelor on Infarct Size in ST-Segment-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (the PITRI Trial)".
     Circulation. 2025;151:e1004-e1005.
     

     >> Share

     
     
150. BOHULA EA, Landzberg MJ, Menon V, Alviar CL, et al
     Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association.
     Circulation. 2025 May 15. doi: 10.1161/CIR.0000000000001334.
     

     >> Share

     
     
151. ZHANG Z, Yang X, Zhang Z
     Letter by Zhang et al Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e986-e987.
     

     >> Share

     
     
152. REITAN C, Andell P, Hofmann R, Jernberg T, et al
     Response by Reitan et al to Letter Regarding Article, "Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study".
     Circulation. 2025;151:e988-e989.
     

     >> Share

     
     
153. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Correction to: Sedentary Behavior and Light-intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025;151:e1000.
     

     >> Share

     
     
154. SATTAR N, Weerakkody GJ, McGuire DK, Kosiborod MN, et al
     The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.
     Circulation. 2025;151:1430-1432.
     

     >> Share

     
     April 2025
155. CLARKE R, Wright N, Lin K, Yu C, et al
     Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
     Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
     

     >> Share

     
     
156. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Correction to: Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2025;151:e965-e966.
     

     >> Share

     
     
157. DONG J, Yang X, Zhang W
     Letter by Dong et al Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e962-e963.
     

     >> Share

     
     
158. BONNESEN K, Heide-Jorgensen U, Schmidt M
     Response by Bonnesen et al to Letter Regarding Article, "Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation".
     Circulation. 2025;151:e964.
     

     >> Share

     
     
159. ISMAHIL MA, Zhou G, Rajasekar S, Gao M, et al
     Splenic CD169(+)Tim4(+) Marginal Metallophilic Macrophages Are Essential for Wound Healing After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.071772.
     

     >> Share

     
     
160. LV H, Wang C, Liu Z, Quan M, et al
     Suppression of the Prostaglandin I2-Type 1 Interferon Axis Induces Extramedullary Hematopoiesis to Promote Cardiac Repair After Myocardial Infarction.
     Circulation. 2025 Apr 28. doi: 10.1161/CIRCULATIONAHA.124.069420.
     

     >> Share

     
     
161. BERRY JD, Zabad N, Kyrouac D, Leonard D, et al
     High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study.
     Circulation. 2025 Apr 21. doi: 10.1161/CIRCULATIONAHA.124.070335.
     

     >> Share

     
     
162. GRAVEN LJ, Kitko L, Abshire Saylor M, Allen L, et al
     Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 17. doi: 10.1161/CIR.0000000000001323.
     

     >> Share

     
     
163. STAMATAKIS E, Biswas RK, Koemel NA, Sabag A, et al
     Dose Response of Incidental Physical Activity Against Cardiovascular Events and Mortality.
     Circulation. 2025;151:1063-1075.
     

     >> Share

     
     
164. WHITAKER KM, Barone Gibbs B, Hivert MF, Makarem N, et al
     Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2025 Apr 10. doi: 10.1161/CIR.0000000000001316.
     

     >> Share

     
     
165. CHEN Q, Zheng A, Xu X, Shi Z, et al
     Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2.
     Circulation. 2025;151:1024-1046.
     

     >> Share

     
     
166. LAM NT, Nguyen NUN, Elhelaly WM, Hsu CC, et al
     Induced Cytokinesis Generates Highly Proliferative Mononuclear Cardiomyocytes at the Expense of Contractility.
     Circulation. 2025;151:1009-1023.
     

     >> Share

     
     
167. BENOWITZ NL
     Predicting Cardiovascular Risk With Use of Various Tobacco Products.
     Circulation. 2025;151:1006-1008.
     

     >> Share

     
     
168. STEG PG, Szarek M, Jukema JW, Bhatt DL, et al
     Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of O
     Circulation. 2025;151:1047-1050.
     

     >> Share

     
     
169. POWELL-WILEY TM, Brewer LC, Burke LE, Hernandez R, et al
     Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314.
     

     >> Share

     
     
170. SITTICHOKKANANON A, Garfield V, Chiesa ST
     Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
     Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
     

     >> Share

     
     
171. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025;151:e865.
     

     >> Share

     
     
172. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025;151:e864.
     

     >> Share

     
     
173. YU M, Cheng X
     Response by Yu and Cheng to Letter Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e769-e770.
     

     >> Share

     
     
174. KAKIZAKI R, Raber L
     Letter by Kakizaki and Raber Regarding Article, "Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial".
     Circulation. 2025;151:e767-e768.
     

     >> Share

     
     March 2025
175. MARX N, Deanfield JE, Mann JFE, Arechavaleta R, et al
     Oral Semaglutide and Cardiovascular Outcomes in Persons With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.
     Circulation. 2025 Mar 29. doi: 10.1161/CIRCULATIONAHA.125.074545.
     

     >> Share

     
     
176. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
     Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
     Circulation. 2025 Mar 28. doi: 10.1161/CIRCULATIONAHA.125.074517.
     

     >> Share

     
     
177. RYAN TD, Bates JE, Kinahan KE, Leger KJ, et al
     Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 19. doi: 10.1161/CIR.0000000000001308.
     

     >> Share

     
     
178. NDUMELE CE, Ferdinand KC, Khan SS
     The Role of Race in Cardiovascular Disease Risk Prediction.
     Circulation. 2025;151:741-743.
     

     >> Share

     
     
179. HULL LE, Aday AW, Bui QM, Luzum JA, et al
     Direct-to-Consumer Genetic Testing for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Mar 13. doi: 10.1161/CIR.0000000000001304.
     

     >> Share

     
     
180. KURAMITSU S, Kawase Y, Shinozaki T, Domei T, et al
     Prevalence and Clinical Outcomes of Discordant Lesions Between Fractional Flow Reserve and Nonhyperemic Pressure Ratios in Clinical Practice: The J-PRIDE Registry.
     Circulation. 2025;151:672-685.
     

     >> Share

     
     
181. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Correction to: Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2025;151:e709.
     

     >> Share

     
     
182. CLAUDEL SE, Verma A
     Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.
     Circulation. 2025;151:716-732.
     

     >> Share

     
     
183. ARUNOTHAYARAJ S, Egred M, Banning AP, Brunel P, et al
     Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.
     Circulation. 2025;151:612-622.
     

     >> Share

     
     
184. KOU S, Lu Z, Deng D, Ye M, et al
     Activation of Imprinted Gene PW1 Promotes Cardiac Fibrosis After Ischemic Injury.
     Circulation. 2025;151:623-639.
     

     >> Share

     
     February 2025
185. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
     2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309.
     

     >> Share

     
     
186. 
     Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
     Circulation. 2025;151:e681.
     

     >> Share

     
     
187. 
     Correction to: Abstract 4139303: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease among Middle Eastern Immigrants in the National Health Interview Survey 2004-2018.
     Circulation. 2025;151:e680.
     

     >> Share

     
     
188. STARK AW, Matthey-de-l'Endroit RL, Ferroni A, Kakizaki R, et al
     Coronary CT Anatomy-Based Prediction of Invasively Assessed Hemodynamic Significance in Middle-Aged Patients With Right Coronary Artery Anomaly: The NARCO Study.
     Circulation. 2025;151:578-580.
     

     >> Share

     
     
189. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
     Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
     Circulation. 2025 Feb 20. doi: 10.1161/CIR.0000000000001297.
     

     >> Share

     
     
190. ARMILLOTTA M, Bergamaschi L, Paolisso P, Belmonte M, et al
     Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non-ST-Segment-Elevation Myocardial Infarction.
     Circulation. 2025 Feb 19. doi: 10.1161/CIRCULATIONAHA.124.070729.
     

     >> Share

     
     
191. NELLIPUDI JA, Kelly B, Hardikar A
     Addressing Cardiovascular Health Inequities in Indigenous Women: Insights from Australia and Global Perspectives.
     Circulation. 2025;151:427-429.
     

     >> Share

     
     
192. WINDFELD-MATHIASEN J, Heerfordt IM, Dalhoff KP, Traerup Andersen J, et al
     Cardiovascular Disease in Anabolic Androgenic Steroid Users.
     Circulation. 2025 Feb 13. doi: 10.1161/CIRCULATIONAHA.124.071117.
     

     >> Share

     
     
193. KIM SM, Kim S, Kim YJ, Kim WY, et al
     Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors.
     Circulation. 2025;151:421-423.
     

     >> Share

     
     
194. BRENNAN SO, Kelly PJ, Gorey S, Synnott P, et al
     Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.
     Circulation. 2025;151:334-336.
     

     >> Share

     
     January 2025
195. DAI J, Zhao J, Xu X, Chen Y, et al
     Long-Term Prognostic Implications of Non-Culprit Lesions in Patients Presenting With an Acute Myocardial Infarction: Is It the Angiographic Stenosis Severity or the Underlying High-Risk Morphology?
     Circulation. 2025 Jan 31. doi: 10.1161/CIRCULATIONAHA.124.071855.
     

     >> Share

     
     
196. HALL EJ, Agarwal S, Cullum CM, Sinha SS, et al
     Survivorship After Cardiogenic Shock.
     Circulation. 2025;151:257-271.
     

     >> Share

     
     
197. SINGER Z, Wijeysundera HC, Qiu F, Fang J, et al
     Driving Restrictions and Incapacitation Vulnerability Evaluation After ST-Segment-Elevation Myocardial Infarction: DRIVE-STEMI Study.
     Circulation. 2025;151:282-284.
     

     >> Share

     
     
198. 
     Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2025;151:e30.
     

     >> Share

     
     
199. MAURICIO R, Sharma G, Lewey J, Tompkins R, et al
     Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association.
     Circulation. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292.
     

     >> Share

     
     
200. CHEN JZ, Liang Y, Liang B
     Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e22.
     

     >> Share

     
     
201. SUN M, He S, Hu J, Zhang Y, et al
     Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction".
     Circulation. 2025;151:e23.
     

     >> Share

     
     
202. SIDIQI AW, Dad Zada D, Exeer NA
     Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine.
     Circulation. 2025;151:129-131.
     

     >> Share

     
     
203. ROGNE T, Gill D
     Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study.
     Circulation. 2025;151:193-195.
     

     >> Share

     
     
204. LIU S, Deshmukh V, Meng F, Wang Y, et al
     Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration.
     Circulation. 2025;151:59-75.
     

     >> Share

     
     
205. CHEW NWS, Mehta A, Goh RSJ, Zhang A, et al
     Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
     Circulation. 2025;151:98-119.
     

     >> Share

     
     December 2024
206. TOMII D, Pilgrim T, Borger MA, De Backer O, et al
     Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and Transcatheter Management.
     Circulation. 2024;150:2046-2069.
     

     >> Share

     
     
207. ZWECK E, Hassager C, Beske RP, Jensen LO, et al
     Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock Trial.
     Circulation. 2024;150:1990-2003.
     

     >> Share

     
     
208. BIRKENFELD AL, Franks PW, Mohan V
     Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
     Circulation. 2024;150:1910-1912.
     

     >> Share

     
     
209. LEWANDOWSKI AJ, Rutter MK, Collins R
     Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine.
     Circulation. 2024;150:1907-1909.
     

     >> Share

     
     
210. JONE PN, Tremoulet A, Choueiter N, Dominguez SR, et al
     Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2024;150:e481-e500.
     

     >> Share

     
     
211. DENNISON HIMMELFARB CR, Benowitz NL, Blank MD, Bhatnagar A, et al
     Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association.
     Circulation. 2024 Dec 3. doi: 10.1161/CIR.0000000000001293.
     

     >> Share

     
     
212. LINDNER JR, Morello M
     In Vivo Cardiovascular Molecular Imaging: Contributions to Precision Medicine and Drug Development.
     Circulation. 2024;150:1885-1897.
     

     >> Share

     
     
213. ARMBRUSTER S, Skali H, Wei LJ
     Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials.
     Circulation. 2024;150:1823-1825.
     

     >> Share

     
     November 2024
214. QIN D, Modanwal R, Kitsis RN
     Extracellular Role for the Intracellular Cell Death Mediator RIPK3 in Myocardial Infarction.
     Circulation. 2024;150:1812-1814.
     

     >> Share

     
     
215. ZHANG W, Zhang J, Wang Z, Li T, et al
     Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury.
     Circulation. 2024;150:1791-1811.
     

     >> Share

     
     
216. ITZHAKI BEN ZADOK O, Simitsis P, Jacobson C, Nadeem O, et al
     Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
     Circulation. 2024;150:1815-1817.
     

     >> Share

     
     
217. JI Y, Zhang MJ, Wang W, Norby FL, et al
     Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS.
     Circulation. 2024 Nov 21. doi: 10.1161/CIRCULATIONAHA.124.070278.
     

     >> Share

     
     
218. MORROW A, Young R, Abraham GR, Hoole S, et al
     Zibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trial.
     Circulation. 2024;150:1671-1683.
     

     >> Share

     
     
219. 
     Correction to: 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Gui
     Circulation. 2024;150:e466.
     

     >> Share

     
     
220. GIUGNI FR, Berry JD, Khera A, Shah AM, et al
     Precision Medicine for Cardiovascular Prevention and Population Health: A Bridge Too Far?
     Circulation. 2024;150:1720-1731.
     

     >> Share

     
     
221. HO FK, Mark PB, Lees JS, Pell JP, et al
     A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia.
     Circulation. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454.
     

     >> Share

     
     
222. GREIF R, Bray JE, Djarv T, Drennan IR, et al
     2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
     Circulation. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288.
     

     >> Share

     
     
223. XU X, Zhu H, Xu K
     Letter by Xu et al Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e444.
     

     >> Share

     
     
224. LIANG Y, Liang B
     Letter by Y. Liang and B. Liang Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e443.
     

     >> Share

     
     
225. YAN Y, Nie S, Montalescot G
     Response by Yan et al to Letter Regarding Article, "Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial".
     Circulation. 2024;150:e445-e446.
     

     >> Share

     
     
226. DEZFULIAN C, McCallin TE, Bierens J, Dunne CL, et al
     2024 American Heart Association and American Academy of Pediatrics Focused Update on Special Circumstances: Resuscitation Following Drowning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardio
     Circulation. 2024 Nov 12. doi: 10.1161/CIR.0000000000001274.
     

     >> Share

     
     
227. KIM Y, Landstrom AP, Shah SH, Wu JC, et al
     Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association.
     Circulation. 2024 Nov 11. doi: 10.1161/CIR.0000000000001296.
     

     >> Share

     
     
228. MA C, Ge J, Han Y
     Global Rounds: Advancing Cardiovascular Health in China.
     Circulation. 2024 Nov 7. doi: 10.1161/CIRCULATIONAHA.124.071544.
     

     >> Share

     
     
229. AVERBUCH T, Stelkia K, Van Spall HGC
     Cardiovascular Care in Canada: Strengths, Challenges, and Opportunities For Improvement.
     Circulation. 2024;150:1490-1492.
     

     >> Share

     
     
230. BHATIA HS, Wandel S, Willeit P, Lesogor A, et al
     Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.069556.
     

     >> Share

     
     
231. DILLON HT, Saner NJ, Ilsley T, Kliman DS, et al
     Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
     Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709.
     

     >> Share

     
     October 2024
232. VAN DIEPEN S, Poss J, Senaratne JM, Gage A, et al
     Mixed Cardiogenic Shock: A Proposal for Standardized Classification, a Hemodynamic Definition, and Framework for Management.
     Circulation. 2024;150:1459-1468.
     

     >> Share

     
     
233. PAPATHEODOROU E, Aengevaeren VL, Eijsvogels TMH, AlFakih K, et al
     Prevalence of Coronary Atherosclerosis in Female Masters Endurance Athletes.
     Circulation. 2024;150:1478-1480.
     

     >> Share

     
     
234. GRAGNANO F, van Klaveren D, Heg D, Raber L, et al
     Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072009.
     

     >> Share

     
     
235. FOLEY MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, et al
     Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease.
     Circulation. 2024 Oct 27. doi: 10.1161/CIRCULATIONAHA.124.072281.
     

     >> Share

     
     
236. SELLKE FW
     Bleeding After Cardiovascular Surgery: A Continuing Problem.
     Circulation. 2024;150:1324-1326.
     

     >> Share

     
     
237. RUEL M, de Lemos J, Fischbein M, Hill JA, et al
     Introduction to the 2024 Cardiovascular Surgery-Themed Issue of Circulation.
     Circulation. 2024;150:1307.
     

     >> Share

     
     
238. HOFMANN C, Serafin A, Schwerdt OM, Fischer J, et al
     Transient Inhibition of Translation Improves Cardiac Function After Ischemia/Reperfusion by Attenuating the Inflammatory Response.
     Circulation. 2024;150:1248-1267.
     

     >> Share

     
     
239. SILBERNAGEL G, Chen YQ, Li H, Lemen D, et al
     Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality.
     Circulation. 2024 Oct 11. doi: 10.1161/CIRCULATIONAHA.124.069272.
     

     >> Share

     
     
240. KRISTENSEN JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, et al
     Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans.
     Circulation. 2024;150:1187-1198.
     

     >> Share

     
     
241. SINNAEVE PR, Welsh RC, Arias Mendoza A, Ristic AD, et al
     Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up.
     Circulation. 2024;150:1151-1153.
     

     >> Share

     
     
242. RUEL M, Chikwe J
     Coronary Artery Bypass Grafting: Past and Future.
     Circulation. 2024;150:1067-1069.
     

     >> Share

     
     
243. KNEUER JM, Grajek IA, Winkler M, Erbe S, et al
     Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing.
     Circulation. 2024;150:1101-1120.
     

     >> Share

     
     September 2024
244. ZHAO X, Williamson T, Gong Y, Epstein JA, et al
     Immunomodulatory Therapy for Ischemic Heart Disease.
     Circulation. 2024;150:1050-1058.
     

     >> Share

     
     
245. DUAN Z, Huang Z, Lei W, Zhang K, et al
     Bone Morphogenetic Protein 9 Protects Against Myocardial Infarction by Improving Lymphatic Drainage Function and Triggering DECR1-Mediated Mitochondrial Bioenergetics.
     Circulation. 2024 Sep 24. doi: 10.1161/CIRCULATIONAHA.123.065935.
     

     >> Share

     
     
246. GIACOPPO D, Laudani C, Occhipinti G, Spagnolo M, et al
     Response by Giacoppo et al to Letter Regarding Article "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e271-e272.
     

     >> Share

     
     
247. ZHANG Z
     Letter by Zhang Regarding Article, "Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis".
     Circulation. 2024;150:e269-e270.
     

     >> Share

     
     
248. KOTWAL SS, Perkovic V
     Kidney Disease as a Cardiovascular Disease Priority.
     Circulation. 2024;150:975-977.
     

     >> Share

     
     
249. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
     2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001285.
     

     >> Share

     
     
250. BROWN TM, Pack QR, Aberegg E, Brewer LC, et al
     Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.
     Circulation. 2024 Sep 24. doi: 10.1161/CIR.0000000000001289.
     

     >> Share

     
     
251. LEE DH
     Microplastics and Cardiovascular Diseases: Importance of Coexisting Environmental Pollutants.
     Circulation. 2024;150:908-910.
     

     >> Share

     
     
252. SHAH NS, Kandula NR, Commodore-Mensah Y, Morey BN, et al
     Social Determinants of Cardiovascular Health in Asian Americans: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Sep 16. doi: 10.1161/CIR.0000000000001278.
     

     >> Share

     
     
253. BUTALA NM, Bucholz EM
     Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained.
     Circulation. 2024;150:836-837.
     

     >> Share

     
     
254. BEI Y, Zhu Y, Zhou J, Ai S, et al
     Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.
     Circulation. 2024;150:848-866.
     

     >> Share

     
     
255. DIWAN A
     The Case for Restoring Organelles to Treat Ischemic Cardiomyopathy: Is DEPP1 an Attractive Target?
     Circulation. 2024;150:787-790.
     

     >> Share

     
     
256. WYANT GA, Jiang Q, Singh M, Qayyum S, et al
     Induction of DEPP1 by HIF Mediates Multiple Hallmarks of Ischemic Cardiomyopathy.
     Circulation. 2024;150:770-786.
     

     >> Share

     
     
257. VOLPP KG
     Using Behavioral Science to Improve Cardiovascular Health.
     Circulation. 2024;150:743-745.
     

     >> Share

     
     
258. SIMON T, Herbert BM, Brooks MM, Goodman SG, et al
     Restrictive or Liberal Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: 6-Month Mortality in the MINT Trial.
     Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.069917.
     

     >> Share

     
     
259. CAMPO G, Bohm F, Engstrom T, Smits PC, et al
     Complete vs. Culprit-Only Revascularization in Older Patients with ST-segment Elevation Myocardial Infarction: An Individual Patient Meta-Analysis.
     Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071493.
     

     >> Share

     
     August 2024
260. BODEN WE, De Caterina R, Kaski JC, Bairey Merz CN, et al
     Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.123.065656.
     

     >> Share

     
     
261. NEUEN BL, Fletcher RA, Heath L, Perkovic A, et al
     Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
     Circulation. 2024 Aug 30. doi: 10.1161/CIRCULATIONAHA.124.071689.
     

     >> Share

     
     
262. DEFILIPPIS AP, Abbott JD, Herbert BM, Bertolet MH, et al
     Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.071208.
     

     >> Share

     
     
263. BONNESEN K, Heide-Jorgensen U, Christensen DH, Lash TL, et al
     Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
     Circulation. 2024 Aug 29. doi: 10.1161/CIRCULATIONAHA.124.068613.
     

     >> Share

     
     
264. DELWARDE C, Aikawa M
     Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
     Circulation. 2024;150:706-709.
     

     >> Share

     
     
265. LI J, Sun S, Zhu D, Mei X, et al
     Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.
     Circulation. 2024;150:710-723.
     

     >> Share

     
     
266. YU M, Yang Y, Dong SL, Zhao C, et al
     Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
     Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069808.
     

     >> Share

     
     
267. KERN MJ, Seto AH
     Does PPG, the Other Dimension to FFR, Better Predict Post-PCI Results?
     Circulation. 2024;150:598-599.
     

     >> Share

     
     
268. KOBAYASHI H, Tohyama S, Ichimura H, Ohashi N, et al
     Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
     Circulation. 2024;150:611-621.
     

     >> Share

     
     
269. KOVILAKATH A, Mauro AG, Valentine YA, Raucci FJ, et al
     SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy.
     Circulation. 2024;150:622-641.
     

     >> Share

     
     
270. ABBATE A, Van Tassell B, Bogin V, Markley R, et al
     Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI).
     Circulation. 2024;150:580-582.
     

     >> Share

     
     
271. MOSLEHI JJ
     Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
     Circulation. 2024;150:513-515.
     

     >> Share

     
     
272. MORRIS SA, Flyer JN, Yetman AT, Quezada E, et al
     Cardiovascular Management of Aortopathy in Children: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Aug 12. doi: 10.1161/CIR.0000000000001265.
     

     >> Share

     
     
273. LIN Y, Gil CH, Banno K, Yokoyama M, et al
     ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
     Circulation. 2024;150:451-465.
     

     >> Share

     
     
274. BITTNER V
     Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
     Circulation. 2024;150:435-438.
     

     >> Share

     
     
275. JOYNT MADDOX KE
     Health Economics of Cardiovascular Disease in the United States.
     Circulation. 2024;150:419-421.
     

     >> Share

     
     
276. MARTINEZ-MORATA I, Schilling K, Glabonjat RA, Domingo-Relloso A, et al
     Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA).
     Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.124.069414.
     

     >> Share

     
     July 2024
277. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2024;150:e105.
     

     >> Share

     
     
278. VALGIMIGLI M, Landi A, Angiolillo DJ, Baber U, et al
     Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.
     Circulation. 2024;150:317-335.
     

     >> Share

     
     
279. ARMSTRONG PW
     Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries.
     Circulation. 2024;150:258-260.
     

     >> Share

     
     
280. GRANT JK, Martin SS, Zhang S, Matsushita K, et al
     Racial Differences in the Burden of Atherosclerotic Cardiovascular Disease Related to Elevated Lipoprotein(a) Levels: The ARIC Study.
     Circulation. 2024;150:250-252.
     

     >> Share

     
     
281. WANG Y, Chen GC, Wang Z, Luo K, et al
     Dietary Acculturation Is Associated With Altered Gut Microbiome, Circulating Metabolites, and Cardiovascular Disease Risk in US Hispanics and Latinos: Results From HCHS/SOL.
     Circulation. 2024;150:215-229.
     

     >> Share

     
     
282. SONG N, Beyene TJ, Amponsah DK, Asch SM, et al
     Novel Use of Z Codes to Identify Social Determinants of Cardiovascular Disease Outcomes.
     Circulation. 2024;150:243-245.
     

     >> Share

     
     
283. ADEDINSEWO D
     Advancing Cardiovascular Health Equity With Artificial Intelligence: A Collective Ethical Responsibility.
     Circulation. 2024;150:174-176.
     

     >> Share

     
     
284. WEYRICH M, Cremer S, Gerster M, Sarakpi T, et al
     Loss of Y Chromosome and Cardiovascular Events in Chronic Kidney Disease.
     Circulation. 2024 Jul 15. doi: 10.1161/CIRCULATIONAHA.124.069139.
     

     >> Share

     
     
285. ABBARA S, Shaw LJ
     Past, Present, and Future of CTA.
     Circulation. 2024;150:87-90.
     

     >> Share

     
     
286. FLEG JL, Huang Z, Reynolds HR, Shaw LJ, et al
     Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA.
     Circulation. 2024;150:165-167.
     

     >> Share

     
     
287. KUEHN BM
     Million Hearts Model Reduces Cardiovascular Events Without Increasing Care Costs.
     Circulation. 2024;150:162-164.
     

     >> Share

     
     
288. REITAN C, Andell P, Alfredsson J, Erlinge D, et al
     Excess Mortality and Loss of Life Expectancy After Myocardial Infarction: A Registry-Based Matched Cohort Study.
     Circulation. 2024 Jul 5. doi: 10.1161/CIRCULATIONAHA.124.068739.
     

     >> Share

     
     
289. BERRY C, Sidik NP, McEntegart MB
     Response by Berry et al to Letter Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e5-e6.
     

     >> Share

     
     
290. NISHI T, Saito Y, Kobayashi Y
     Letter by Nishi et al Regarding Article, "Invasive Endotyping in Patients With Angina and No Obstructive Coronary Artery Disease: A Randomized Controlled Trial".
     Circulation. 2024;150:e3-e4.
     

     >> Share

     
     June 2024
291. KIM K, Joyce BT, Zheng Y, Nannini DR, et al
     Associations of Urban Blue and Green Spaces With Coronary Artery Calcification in Black Individuals and Disadvantaged Neighborhoods.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.123.067992.
     

     >> Share

     
     
292. TANNU M, Kaltenbach L, Pagidipati NJ, McGuire DK, et al
     Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial.
     Circulation. 2024 Jun 27. doi: 10.1161/CIRCULATIONAHA.124.068962.
     

     >> Share

     
     
293. LIU T, Hao Y, Zhang Z, Zhou H, et al
     Advanced Cardiac Patches for the Treatment of Myocardial Infarction.
     Circulation. 2024;149:2002-2020.
     

     >> Share

     
     
294. JHA AK
     Letter by Jha Regarding Article, "Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial".
     Circulation. 2024;149:e1415-e1416.
     

     >> Share

     
     
295. ZHANG S, Zhang Y, Duan X, Wang B, et al
     Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism.
     Circulation. 2024;149:1982-2001.
     

     >> Share

     
     
296. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
     Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
     Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
     

     >> Share

     
     
297. MIYAUCHI K, Iwata H, Nishizaki Y, Inoue T, et al
     Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid (RESPECT-EPA).
     Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.123.065520.
     

     >> Share

     
     
298. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1411.
     

     >> Share

     
     
299. HUNDLEY WG
     Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis.
     Circulation. 2024;149:1859-1861.
     

     >> Share

     
     
300. ANDREOTTI F, Burzotta F, Maggioni AP
     Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance".
     Circulation. 2024;149:e1312.
     

     >> Share

     
     
301. GURAGAIN B, Wei Y, Zhang H, Kahn-Krell A, et al
     Implanted Human Cardiac Spheroids Electrically Couple With Infarcted Swine Myocardium.
     Circulation. 2024;149:1855-1857.
     

     >> Share

     
     
302. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
     Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
     

     >> Share

     
     
303. MORAN AE, Goldman L
     Predicting the Future Prevalence of Cardiovascular Disease: The Good, the Bad, the Known, and the Unknown.
     Circulation. 2024 Jun 4. doi: 10.1161/CIRCULATIONAHA.124.070265.
     

     >> Share

     
     
304. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
     Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
     Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
     

     >> Share

     
     May 2024
305. MEHTA LS, Churchwell K, Coleman D, Davidson J, et al
     Fostering Psychological Safety and Supporting Mental Health Among Cardiovascular Health Care Workers: A Science Advisory From the American Heart Association.
     Circulation. 2024 May 30. doi: 10.1161/CIR.0000000000001259.
     

     >> Share

     
     
306. NAKAMORI S, Amyar A, Fahmy AS, Ngo LH, et al
     Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy.
     Circulation. 2024 May 29. doi: 10.1161/CIRCULATIONAHA.123.067107.
     

     >> Share

     
     
307. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
     Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
     Circulation. 2024;149:1729-1748.
     

     >> Share

     
     
308. ZHAI X, Cao S, Wang J, Qiao B, et al
     Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
     Circulation. 2024;149:1752-1769.
     

     >> Share

     
     
309. 
     Correction to: 2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1218.
     

     >> Share

     
     
310. SATTAR N, Neeland IJ, McGuire DK
     Obesity and Cardiovascular Disease: A New Dawn.
     Circulation. 2024;149:1621-1623.
     

     >> Share

     
     
311. ZHU Q, Scherer PE
     Ceramides and Atherosclerotic Cardiovascular Disease: A Current Perspective.
     Circulation. 2024;149:1624-1626.
     

     >> Share

     
     
312. BULLUCK H, Chong JH, Bryant J, Annathurai A, et al
     Effect of Cangrelor on Infarct Size in ST-Segment Elevation Myocardial Infarction Treated By Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial).
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.068938.
     

     >> Share

     
     
313. COLLET C, Munhoz D, Mizukami T, Sonck J, et al
     Influence of Pathophysiological Patterns of Coronary Artery Disease on Immediate Percutaneous Coronary Intervention Outcomes.
     Circulation. 2024 May 14. doi: 10.1161/CIRCULATIONAHA.124.069450.
     

     >> Share

     
     
314. 
     Correction to: An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
     Circulation. 2024;149:e1189-e1190.
     

     >> Share

     
     
315. TANG WHW, Hazen SL
     Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases.
     Circulation. 2024;149:1543-1545.
     

     >> Share

     
     
316. MORRISON JT, Canonico ME, Anand SS, Patel MR, et al
     Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.
     Circulation. 2024;149:1536-1539.
     

     >> Share

     
     April 2024
317. KELHAM M, Mathur A, Jones DA
     Response by Kelham et al to Letter Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1133.
     

     >> Share

     
     
318. APOSTOLOS A, Karamasis GV, Tsigkas G
     Letter by Apostolos et al Regarding Article, "Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial".
     Circulation. 2024;149:e1132.
     

     >> Share

     
     
319. ZAMAN S, Edwards NC, Chew DP
     Global Rounds: Cardiovascular Care in Australia and New Zealand.
     Circulation. 2024;149:1402-1404.
     

     >> Share

     
     
320. SOLOMON CG, Landrigan PJ
     Fossil Fuels, Climate Change, and Cardiovascular Disease: A Call to Action.
     Circulation. 2024;149:1400-1401.
     

     >> Share

     
     
321. LEMESLE G, Lamblin N, Schurtz G, Labreuche J, et al
     Comparison of Incidence and Prognostic Impact of Ischemic Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
     Circulation. 2024 Apr 25. doi: 10.1161/CIRCULATIONAHA.123.067938.
     

     >> Share

     
     
322. GIRI J, Kaneko T
     Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease.
     Circulation. 2024;149:1339-1340.
     

     >> Share

     
     
323. SHAH SH, Gerszten RE
     Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age.
     Circulation. 2024;149:1323-1325.
     

     >> Share

     
     
324. SWAIN L, Bhave S, Qiao X, Reyelt L, et al
     Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
     Circulation. 2024;149:1341-1353.
     

     >> Share

     
     
325. 
     Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Su
     Circulation. 2024;149:e1128.
     

     >> Share

     
     
326. GOLDFARB MJ, Saylor MA, Bozkurt B, Code J, et al
     Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Apr 11. doi: 10.1161/CIR.0000000000001233.
     

     >> Share

     
     
327. PATEL SM, Kang YM, Im K, Neuen BL, et al
     Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069568.
     

     >> Share

     
     
328. FANAROFF AC, Patel MS, Chokshi N, Coratti S, et al
     Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial.
     Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069531.
     

     >> Share

     
     
329. HERNANDEZ AF, Udell JA, Jones WS, Anker SD, et al
     Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.124.069217.
     

     >> Share

     
     
330. CHO L, Plutzky J, Brennan D, Louie MJ, et al
     Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex.
     Circulation. 2024 Apr 6. doi: 10.1161/CIRCULATIONAHA.123.067691.
     

     >> Share

     
     
331. MAEHARA A, Sugizaki Y
     Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?
     Circulation. 2024;149:1087-1089.
     

     >> Share

     
     
332. BLUMER V, Kanwar MK, Barnett CF, Cowger JA, et al
     Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association.
     Circulation. 2024;149:e1051-e1065.
     

     >> Share

     
     
333. WU JC, Wilson BH, Fang JC, Hurwitz JL, et al
     Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
     Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553.
     

     >> Share

     
     March 2024
334. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
     Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
     Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
     

     >> Share

     
     
335. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
     Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
     Circulation. 2024;149:1033-1052.
     

     >> Share

     
     
336. SERRUYS PW, Revaiah PC
     The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
     Circulation. 2024;149:973-978.
     

     >> Share

     
     
337. FENG J, Li Y, Li Y, Yin Q, et al
     Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
     Circulation. 2024;149:1004-1015.
     

     >> Share

     
     
338. 
     Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2024;149:e1023.
     

     >> Share

     
     
339. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
     Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
     Circulation. 2024;149:1056-1058.
     

     >> Share

     
     
340. TENG Z, Ma Y, Ma X
     Letter by Teng et al Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e960-e961.
     

     >> Share

     
     
341. FRANGOGIANNIS NG
     Response by Frangogiannis to Letter Regarding Article, "Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction".
     Circulation. 2024;149:e962-e963.
     

     >> Share

     
     
342. MARANO P, Mouapi K, Kim A, Mastali M, et al
     Apolipoproteins Quantified Using Blood Volumetric Absorptive Microsampling and High-Throughput Mass Spectrometry for Risk Assessment in Ischemic Heart Disease.
     Circulation. 2024;149:970-972.
     

     >> Share

     
     
343. EVERETT BM
     The Confusing Landscape of Cardiovascular Health Assessment, Promotion, and Prediction.
     Circulation. 2024;149:914-916.
     

     >> Share

     
     
344. LANDSTROM AP, Chahal CAA, Roden DM, Ho CY, et al
     A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
     Circulation. 2024;149:902-904.
     

     >> Share

     
     
345. JUNCA G, Delgado V
     Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
     Circulation. 2024;149:822-824.
     

     >> Share

     
     
346. HEUTS S, Myers PO, Siepe M
     Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:892-893.
     

     >> Share

     
     
347. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
     Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:894-895.
     

     >> Share

     
     
348. ZIMMERMANN FM, Ding VY, Fearon WF
     Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
     Circulation. 2024;149:896.
     

     >> Share

     
     
349. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
     Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
     Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
     

     >> Share

     
     
350. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
     Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
     Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
     

     >> Share

     
     
351. ALEXANDER T, Kumbhani DJ, Mullasari Sankardas A
     The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.
     Circulation. 2024;149:732-733.
     

     >> Share

     
     
352. RAJAGOPALAN S, Brook RD
     Cardiovascular and Planetary Health: Two Sides of the Same Planet.
     Circulation. 2024;149:729-731.
     

     >> Share

     
     February 2024
353. CHEN Z, Zhang J, He Y
     Letter by Chen et al Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:725-726.
     

     >> Share

     
     
354. VAN DE WERF F, Sinnaeve P, Welsh RC, Armstrong PW, et al
     Response by Van de Werf et al to Letter Regarding Article, "STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial".
     Circulation. 2024;149:727-728.
     

     >> Share

     
     
355. GAFFEY AE, Rollman BL, Burg MM
     Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component.
     Circulation. 2024;149:641-643.
     

     >> Share

     
     
356. DZAU VJ, Hodgkinson CP
     RNA Therapeutics for the Cardiovascular System.
     Circulation. 2024;149:707-716.
     

     >> Share

     
     
357. YAN Y, Guo J, Wang X, Wang G, et al
     Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
     Circulation. 2024 Feb 26. doi: 10.1161/CIRCULATIONAHA.123.067079.
     

     >> Share

     
     October 2023
358. GAUDINO M, Sandner S, An KR, Dimagli A, et al
     Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
     Circulation. 2023;148:1305-1315.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share